This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brainard, D. M.
Right arrow Articles by Poznansky, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brainard, D. M.
Right arrow Articles by Poznansky, M. C.

 Previous Article  |  Next Article 

Journal of Virology, May 2004, p. 5184-5193, Vol. 78, No. 10
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.10.5184-5193.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Migration of Antigen-Specific T Cells Away from CXCR4-Binding Human Immunodeficiency Virus Type 1 gp120

Diana M. Brainard,1 William G. Tharp,1 Elva Granado,1 Nicholas Miller,1 Alicja K. Trocha,1 Xiang-Hui Ren,2 Brian Conrad,3 Ernest F. Terwilliger,2 Richard Wyatt,4 Bruce D. Walker,1 and Mark C. Poznansky1*

Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114,1 Department of Mathematics, University of Michigan, Ann Arbor, Michigan 48109,3 Division of Experimental Medicine, Beth Israel Deaconess Medical Center, and Harvard Institutes of Medicine,2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 021154

Received 14 October 2003/ Accepted 22 January 2004

Cell-mediated immunity depends in part on appropriate migration and localization of cytotoxic T lymphocytes (CTL), a process regulated by chemokines and adhesion molecules. Many viruses, including human immunodeficiency virus type 1 (HIV-1), encode chemotactically active proteins, suggesting that dysregulation of immune cell trafficking may be a strategy for immune evasion. HIV-1 gp120, a retroviral envelope protein, has been shown to act as a T-cell chemoattractant via binding to the chemokine receptor and HIV-1 coreceptor CXCR4. We have previously shown that T cells move away from the chemokine stromal cell-derived factor 1 (SDF-1) in a concentration-dependent and CXCR4 receptor-mediated manner. Here, we demonstrate that CXCR4-binding HIV-1 X4 gp120 causes the movement of T cells, including HIV-specific CTL, away from high concentrations of the viral protein. This migratory response is CD4 independent and inhibited by anti-CXCR4 antibodies and pertussis toxin. Additionally, the expression of X4 gp120 by target cells reduces CTL efficacy in an in vitro system designed to account for the effect of cell migration on the ability of CTL to kill their target cells. Recombinant X4 gp120 also significantly reduced antigen-specific T-cell infiltration at a site of antigen challenge in vivo. The repellant activity of HIV-1 gp120 on immune cells in vitro and in vivo was shown to be dependent on the V2 and V3 loops of HIV-1 gp120. These data suggest that the active movement of T cells away from CXCR4-binding HIV-1 gp120, which we previously termed fugetaxis, may provide a novel mechanism by which HIV-1 evades challenge by immune effector cells in vivo.


* Corresponding author. Mailing address: Partners AIDS Research Center, 149 13th St., 5th Floor, Charlestown, MA 02139. Phone: (617) 724-6375. Fax: (501) 646-1163. E-mail: mpoznansky{at}partners.org.


Journal of Virology, May 2004, p. 5184-5193, Vol. 78, No. 10
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.10.5184-5193.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Stevceva, L., Yoon, V., Carville, A., Pacheco, B., Santosuosso, M., Korioth-Schmitz, B., Mansfield, K., Poznansky, M. C. (2008). The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo. J. Immunol. 181: 5510-5521 [Abstract] [Full Text]  
  • Vasiliver-Shamis, G., Tuen, M., Wu, T. W., Starr, T., Cameron, T. O., Thomson, R., Kaur, G., Liu, J., Visciano, M. L., Li, H., Kumar, R., Ansari, R., Han, D. P., Cho, M. W., Dustin, M. L., Hioe, C. E. (2008). Human Immunodeficiency Virus Type 1 Envelope gp120 Induces a Stop Signal and Virological Synapse Formation in Noninfected CD4+ T Cells. J. Virol. 82: 9445-9457 [Abstract] [Full Text]  
  • Vianello, F., Papeta, N., Chen, T., Kraft, P., White, N., Hart, W. K., Kircher, M. F., Swart, E., Rhee, S., Palu, G., Irimia, D., Toner, M., Weissleder, R., Poznansky, M. C. (2006). Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control.. J. Immunol. 176: 2902-2914 [Abstract] [Full Text]  
  • Balabanian, K., Harriague, J., Decrion, C., Lagane, B., Shorte, S., Baleux, F., Virelizier, J.-L., Arenzana-Seisdedos, F., Chakrabarti, L. A. (2004). CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes. J. Immunol. 173: 7150-7160 [Abstract] [Full Text]